CDMO 360

LinkedInnewsletter · by Tom Wieland

Bi-Weekly Breakdown of the CDMO Space

Investigate Sign in to visit
Audience
Not shown publicly
We show a dash rather than guess
Publishing
Every two weeks
5 posts indexed in the last 90 days
Last post
Oct 22, 2026
9 days ago
Likely audience
Pharmaceutical executives
Inferred from post content

CDMO 360 is a LinkedIn newsletter by Tom Wieland covering CDMO industry, biologics manufacturing and gene therapy. NewsletterFIT indexed 5 posts from it in the last 90 days, most recently on Oct 22, 2026.

Topics

Recent posts

  • CDMO 360…
  • CDMO 360…
  • CDMO 360…
  • CDMO 360…
  • CDMO 360…

Sponsors detected

No sponsored posts detected in the last 180 days of indexed posts.

Detected automatically from posts marked as sponsored. Detection can miss or misread placements.

See the full picture on CDMO 360

Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.

Start 7-day Pro trial

Similar newsletters

Ranked by how many topics they share with CDMO 360.

  • Unreported Truths223K subscribers

    SubstackWeekly · last post 17 days ago

    Likely audience: public health professionals

    1 shared topic

  • Solar Kitties | Energy & Longevity108K subscribers

    SubstackEvery two weeks · last post 33 days ago

    Likely audience: biotech investors

    1 shared topic

  • The Microdose89K subscribers

    SubstackEvery two weeks · last post 22 days ago

    Likely audience: Healthcare policy makers

    1 shared topic

  • Dr. Noc, PhD67K subscribers

    SubstackEvery two weeks · last post 20 days ago

    Likely audience: Health-conscious individuals

    1 shared topic

  • Dr Paddy Barrett37K subscribers

    SubstackEvery two weeks · last post 15 days ago

    Likely audience: Cardiologists and lipid specialists

    1 shared topic

  • MD REPORTS27K subscribers

    SubstackEvery two weeks · last post 23 days ago

    Likely audience: Public health advocates

    1 shared topic

  • Repurposed Drugs: Powers & Possibilities24K subscribers

    SubstackEvery two weeks · last post 16 days ago

    Likely audience: Public health officials

    1 shared topic

  • Thought Leader19K subscribers

    SubstackEvery two weeks · last post 24 days ago

    Likely audience: Medical professionals and neurosurgeons

    1 shared topic

Compiled from public pages · refreshed Nov 1, 2026 · How NewsletterFIT collects and labels data